Testing pancreatic lab samples to guide future treatments
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal guardian) agree to sign informed consent before any study steps.
- You are 18 years or older, with an expected survival of more than 3 months.
- Your pancreatic cancer is confirmed by pathology, or you have suspected non-spread (non-metastatic) locally advanced pancreatic cancer and are scheduled for a diagnostic EUS-guided biopsy (EUS-FNB).
- Your body can handle the procedure and study tests: energy level (ECOG/WHO) is 0–1.
- Your blood and organ test results are within certain ranges (enough white blood cells and platelets, and acceptable liver/kidney blood tests).
- You can safely receive sedation with propofol during the nurse-administered sedation setup and can safely have the EUS-FNB biopsy; if not, you cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This study uses a personalized blood test to look for tiny pieces of tumor DNA in people with pancreatic cancer. It helps doctors understand how the cancer changes during treatment.
This trial is for people who had surgery for pancreatic cancer and are now deciding on maintenance therapy. A special blood test (ctDNA) may help doctors choose the best follow-up treatment to prevent the cancer from coming back.
This study will take a close-up look at your pancreatic tumor by using a sample from a biopsy to create a personal profile. The goal is to understand your cancer better and maybe find the best treatment for you.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.